Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,571.56
(
0.10%
)
US TECH 100
29,454.80
(
0.10%
)
Dow Jones
50,974.02
(
0.60%
)
Brent Oil
90.85
(
-1.45%
)
Bitcoin
73,942.57
(
0.55%
)
News Focus
News Focus
Post# of 820
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ALERTS100%to10000%GAIN

Send PM Follow Ignore
Followers 1079
Posts 81299
Boards Moderated 5
Alias Born 03/10/2009

ALERTS100%to10000%GAIN

Member Level

Re: Silver Taurus post# 430

Friday, 07/26/2019 7:37:21 AM

Friday, July 26, 2019 7:37:21 AM

Post# of 820
VSTM HUGE DUDEEE<<“the Company”), today announced their entry into an exclusive licensing agreement with Sanofi to develop and commercialize Verastem Oncology’s COPIKTRA® (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K), and the first approved dual inhibitor of PI3K-delta and PI3K-gamma, for the treatment of all oncology indications in Russia and CIS, Turkey, the Middle East and Africa.

STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent VSTM News
More VSTM News